The Bowen–Conradi syndrome protein Nep1 (Emg1) has a dual role in eukaryotic ribosome biogenesis, as an essential assembly factor and in the methylation of Ψ1191 in yeast 18S rRNA by Meyer, Britta et al.
The Bowen–Conradi syndrome protein Nep1 (Emg1)
has a dual role in eukaryotic ribosome biogenesis,
as an essential assembly factor and in the
methylation of )1191 in yeast 18S rRNA
Britta Meyer
1,2, Jan Philip Wurm
2,3, Peter Ko ¨tter
1,2, Matthias S. Leisegang
1,2,
Valeska Schilling
1,2, Markus Buchhaupt
1,2, Martin Held
1,4, Ute Bahr
1,4, Michael Karas
1,4,
Alexander Heckel
1,4, Markus T. Bohnsack
1,2, Jens Wo ¨hnert
2,3 and Karl-Dieter Entian
1,2,*
1Cluster of Excellence Frankfurt: Macromolecular Complexes,
2Institute for Molecular Biosciences,
3Center of Biomolecular Magnetic Resonance (BMRZ) and
4Institute for Pharmaceutical Chemistry,
Johann-Wolfgang Goethe University, Max-von-Laue Str. 9, D-60438 Frankfurt/M., Germany
Received March 18, 2010; Revised September 10, 2010; Accepted September 28, 2010
ABSTRACT
The Nep1 (Emg1) SPOUT-class methyltransferase is
an essential ribosome assembly factor and the
human Bowen–Conradi syndrome (BCS) is caused
by a specific Nep1
D86G mutation. We recently
showed in vitro that Methanocaldococcus jannaschii
Nep1 is a sequence-specific pseudouridine-
N1-methyltransferase. Here, we show that in yeast
the in vivo target site for Nep1-catalyzed methyla-
tion is located within loop 35 of the 18S rRNA that
contains the unique hypermodification of U1191 to
1-methyl-3-(3-amino-3-carboxypropyl)-pseudouri-
dine (m1acp3)). Specific
14C-methionine labelling of
18S rRNA in yeast mutants showed that Nep1 is not
required for acp-modification but suggested a
function in )1191 methylation. ESI MS analysis of
acp-modified )-nucleosides in a Dnep1-mutant
showed that Nep1 catalyzes the )1191 methyla-
tion in vivo. Remarkably, the restored growth
of a nep1-1
ts mutant upon addition of
S-adenosylmethionine was even observed after
preventing U1191 methylation in a Dsnr35 mutant.
This strongly suggests a dual Nep1 function, as
)1191-methyltransferase and ribosome assembly
factor. Interestingly, the Nep1 methyltransferase
activity is not affected upon introduction of the
BCS mutation. Instead, the mutated protein shows
enhanced dimerization propensity and increased
affinity for its RNA-target in vitro. Furthermore, the
BCS mutation prevents nucleolar accumulation of
Nep1, which could be the reason for reduced
growth in yeast and the Bowen-Conradi syndrome.
INTRODUCTION
Eukaryotic ribosome biogenesis is highly regulated and
much more complex than the corresponding pathway in
prokaryotes. A large number of proteins and small nucle-
olar RNAs (snoRNAs) are involved in addition to the
four rRNAs and  80 core proteins of eukaryotic ribo-
somes. These non-ribosomal proteins and snoRNAs
fulﬁl major functions in either rRNA modiﬁcation or
ribosome assembly. In conjunction with rRNA process-
ing, ribosomal proteins and non-ribosomal factors
assemble into pre-ribosomal particles in which further
maturation steps take place (1,2). In fast-growing yeast
cells, up to 2000 ribosomes are synthesized per minute
and  10% of the genomic information is needed for the
biosynthesis of a ribosome (3). This includes more than
180 trans-acting proteins (e.g. nucleases, RNA-helicases
and RNA-modifying enzymes), and  75 small nucleolar
RNAs (snoRNAs) (4,5). Numerous trans-acting proteins
have orthologous functions in many eukaryotes, which
allow the use of model organisms to understand their
physiological function. In case of proteins involved in eu-
karyotic ribosome biogenesis, most of our knowledge was
obtained from studies with baker’s yeast (Saccharomyces
cerevisiae) (6).
Most of the ribosome assembly steps take place in the
nucleolus, a subcompartment of the nucleus organized
around the rRNA-encoding region of the genome. This
includes a large number of speciﬁc co-transcriptional
and posttranscriptional modiﬁcations of rRNA nucleotides.
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methylations and pseudouridylations mediated by box
C/D or H/ACA snoRNA-guided enzymes, respectively
(7,8). In addition, some base modiﬁcations are introduced
by speciﬁc and snoRNA-independent enzymes. In yeast,
the N-dimethylation of two neighbouring adenosines
at the 30 end of 18S rRNA is catalyzed by Dim1 (9), and
recently Bud23 was shown to catalyze the N7-methylation
of guanosine 1575 (10). The unique hypermodiﬁcation of
U1191 in yeast 18S rRNA (U1248 of human 18S rRNA)
to m1acp3 (11) is located in the decoding domain of the
ribosome and was recently suggested to be of importance
for efﬁcient 18S rRNA maturation and ribosome
formation (12). The ﬁrst step in introducing this
hypermodiﬁcation is the conversion from uridine to
pseudouridine by the snR35 containing H/ACA-snoRNP
(13). Thereafter, 1191 becomes N1-methylated in the
nucleolus, whereas the acp-modiﬁcation is added in the
cytoplasm (14). The methyl group as well as the
acp-group are derived from S-adenosylmethionine
(15,16), but the enzymes responsible for this
hypermodiﬁcation in eukaryotic cells are still unknown.
For the archaeon Haloferax volcanii a 3-(3-amino-3-
carboxypropyl)-uridine (acp3U) modiﬁcation and for
Methanocaldococcus jannaschii a nucleotide modiﬁcation
of unknown structure was shown to be present at the
position homologous to yeast 1191 (17).
An increasing number of rare autosomal-inherited
human diseases have recently been attributed to mutations
in proteins required for ribosome biogenesis and/or
function (18). Many of these diseases show bone marrow
defects, anaemia and severe developmental defects (19).
The SBDS gene responsible for Shwachman–Bodian–
Diamond syndrome (SBDS) encodes a homologue to the
Sdo1 protein of S. cerevisiae, which is involved in the mat-
uration of the 60S ribosomal subunit. SBDS patients show
abnormal expression of ribosomal proteins, rRNA trans-
cription- and rRNA-processing proteins (20). About 25%
of the patients suffering from Diamond–Blackfan anaemia
(DBA) carry mutations in the ribosomal protein Rps19
(21), which is important for the 30 maturation of 18S
rRNA in yeast and human cells (22–24).
We have recently shown that a speciﬁc point mutation
within the Nep1 ribosome assembly protein, also referred
to as Emg1 (25,26), causes Bowen–Conradi syndrome
[BCS (MIM 211180)] (27). BCS results in severe pre-
and postnatal growth and psychomotor retardation,
microcephaly, micrognathia, rocker bottom feet and
early childhood death (28). So far most BCS cases are
found in high frequency in Hutterite families (1 in 355
births), but the recent identiﬁcation of the BCS mutation
is expected to result in an increasing number of identiﬁable
cases outside the Hutterite population.
Nep1 is highly conserved in eukaryotes and the human
Nep1 orthologue complements the function in a yeast
ScDnep1 deletion (25,26). Nep1 is essential for 40S ribo-
somal subunit maturation (25,26) and our data suggested
Nep1 to be involved in a methylation reaction (26).
Recently, crystal structures of yeast Nep1 (ScNep1) (29)
and its homologue from the archaeon M. jannaschii
(MjNep1) (30) were solved. Both revealed folds typical
for the SPOUT-family of methyltransferases (31).
Members of the SPOUT family are known to introduce
posttranscriptional S-adenosylmethionine-dependent
RNA-methylations at 20-OH-groups, at guanosine N1 or
at the N3-atom of uridines or pseudouridines (32,33). The
crystal structure of the MjNep1 dimer revealed a positive-
ly charged surface area poised for RNA-binding in a cleft
at the dimer interface (30). Recently, we have shown that
MjNep1 methylates -residues at the N1-position in vitro
in a sequence-speciﬁc manner (34). The preference of
MjNep1 for sequences resembling helix 35 in M. jannaschii
18S rRNA suggested that Nep1 might be responsible for a
similar modiﬁcation in vivo.
Here, we show for the ﬁrst time that Nep1 speciﬁcally
catalyzes the N1-methylation step during the biosynthesis
of the unique hypermodiﬁed m1acp3 at position
1191 within loop 35 of eukaryotic 18S rRNA in vivo.
Interestingly, the BCS mutation does not affect
-methylation per se, but instead prevents the nucleolar
localization of Nep1. Our data support a dual role of
Nep1 as a methyltransferase and as a ribosome assembly
factor and also provide reasons for the malfunction of the
mutant protein in ribosome biogenesis and the BCS.
MATERIALS AND METHODS
Gene and protein nomenclature
The yeast NEP1 gene is referred to as ScNEP1, the human
NEP1 gene as HsNEP1 and the M. jannaschii NEP1 gene
as MjNEP1. The respective proteins are referred to as
ScNep1, HsNep1 and MjNep1.
Plasmid constructions and yeast strains
Detailed descriptions are available in Supplementary
Data.
Yeast media
Yeast strains were grown at 30 C (if not otherwise noted)
in YEPD medium (1% yeast extract, 2% peptone, 2–4%
glucose) or in synthetic dropout medium (0.5%
ammonium sulphate, 0.17% yeast nitrogen base, 2–4%
glucose). For selection on KanMX, G418 was added to
the medium (0.2mg/ml). For growth analysis of tc
aptamer containing strains, cells were serially diluted
and spotted on YEPD plates containing 0, 20 or 50mM
tetracycline. Growth was recorded after 3 days of incuba-
tion at 30 C in the dark. Diploid cells were sporulated on
1% potassium acetate plates for 3 days at 30 C.
Generation of stable human cell lines
Sequences coding for human HsNep1 wild type or the
D86G mutant were cloned into a pcDNA5/FRT/TO de-
rivative for transfection of Flp-In T-REx-293T cells using
the Flp-In T-REx system (Invitrogen). Stable 293T cell
lines that express GFP fusions of human Nep1 wild type
(HsNep1-GFP) or the Nep1
D86G mutant (HsNep1
D86G-
GFP) under control of the tetracycline-inducible
promoter were generated according to the manufacturer’s
protocol.
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For speciﬁc isotope labelling of the 18S rRNA
aminocarboxypropyl group yeast cells were grown with
L-[1-
14C]-methionine. To enhance
14C-labelling each
utilized yeast strain carried a deletion of MET13
(ScDmet13), a gene encoding for the methylenetetrahy-
drofolate reductase involved in methionine biosynthesis
(35). The ScDmet13 deleted strains were grown in synthet-
ic medium with 20mM methionine until OD600 of 2.5, har-
vested by centrifugation and adjusted to OD600 of 0.8 with
methionine-free medium to which L-[1-
14C]-methionine
(Hartmann Analytic, 0.1mCi/ml, 54mCi/mmol) was
added rapidly to a ﬁnal concentration of 18.5mM with
an activity of 1mCi/ml. After incubation at 30 C for one
generation time, cells were harvested by centrifugation.
Preparation of total rRNA
Total RNA from isotope labelled cells was isolated using
the RNeasy Kit (QIAGEN) following the protocol for
enzymatic cell lysis. Ribosomal RNAs were separated on
a 4% denaturing polyacrylamide gel. For detection of
speciﬁc 18S rRNA-labelling with L-[1-
14C]-methionine
gels were stained with ethidium bromide, dried and
analysed by autoradiography for 3–5 days using a
storage phosphor screen. Signals were visualized with
the Typhoon 9100 (GE Healthcare).
Separation and Isolation of 18S rRNA
rRNA was separated on a 4% acrylamide gel with 8M
urea. For the isolation of
14C-labelled 18S rRNA, total
RNA was separated and 18S rRNAs were eluted from
gel slices with 2M ammoniumacetate pH 5.3 (0.4ml per
0.5cm
2 gel, overnight incubation at 4 C). Eluted rRNA
was precipitated with 2.5vol 100 % ethanol and 1vol 8M
lithium chloride, and ﬁnally dissolved in water.
For large-scale preparation of 18S rRNA, exponentially
growing cells from 2l YEPD medium were harvested and
cell extracts were prepared using glass beads in a ribosome
buffer without MgCl2 (50mM Tris–HCl pH 7.6, 50mM
NaCl, 1mM DTT). Ribosome subunits were separated by
gradient ultracentrifugation using 20–50% sucrose gradi-
ents in a SW28 rotor (Beckmann) for 21h at 20000r.p.m.
40S subunits were collected with the Density Gradient
Fractionation System (Teledyne Isco) and precipitated
with 2vol of 100% ethanol at 4 C for 16h. Precipitated
40S subunits were dissolved in water and 18S rRNA was
puriﬁed using the RNeasy Kit (QIAGEN) following the
protocol for RNA cleanup. RNA was eluted in three sub-
sequent steps with 35ml water each.
High-performance liquid chromatography
18S rRNA was hydrolysed and dephosphorylated as pre-
viously described (36). Nucleosides from
14C-labeling ex-
periments were separated by RP-HPLC on an HXSil
C18-Column (Hamilton, 250 4.6mm, 5mm) on an
Agilent 1200 HPLC system. Buffer A (0.25M
ammonium acetate pH 6.0) and buffer B (40% acetoni-
trile) were used with the following HPLC conditions: ﬂow
rate 1.2ml/min; 0% B for 2min, to 50% B over 20min, to
100% B over 5min, held at 100% B for 3min. Fractions
of 15s were collected and radioactivity was measured in a
Wallac 1401 scintillation counter. Large-scale high-per-
formance liquid chromatography (HPLC) experiments
(100pmol 18S rRNA) were performed using a Supelcosil
LC-18-S column (Sigma; 250 4.6mm, 5mm) with a
pre-column (4.6 20mm) following the gradient condi-
tions previously described (33). For mass spectrometry
analysis nucleosides were collected from large-scale
HPLC experiments and desalted twice over a Zorbax
Eclipse XDB-C18 column (Agilent; 4.6 150mm, 5mm)
using 5mM ammonium acetate pH 6.0 with a ﬂow rate
of 0.5ml/min. After buffer evaporation, samples were
resolved in water and applied to ESI mass spectrometry
on a MicroTof-QII (Bruker) in the negative ion mode.
5mM TEAA buffer pH 7.0 with methanol (50%) was
used as mobile phase.
Western blot analysis of 3xHA-Nep1
Protein extracts from HA-epitope tagged yeast strains
were prepared using glass beads. Twenty micrograms
total protein of each sample were separated with 12%
sodium dodecyl sulphate (SDS) polyacrylamide gels and
blotted on PVDF membranes (Millipore). Membranes
were blocked with 5% non-fat dry milk and tagged
proteins were detected with anti-HA monoclonal
antibody (Roche; 1:1000 dilution) followed by anti-mouse
IgG-conjugated horseradish peroxidase (BioRad; 1:10000
dilution).
Protein localization
Yeast cells containing GFP-ScNep1 fusion encoding
plasmids and a chromosomally integrated gene encoding
for ScNop56-mRFP were grown to mid-logarithmic phase
in synthetic medium lacking histidine. Protein localization
was visualized using a Leica TCS SP5.
Expression of human HsNep1-GFP wild type or the
HsNep1
D86G-GFP mutant fusion proteins under control
of the tetracycline-inducible promoter in stable 293T cell
lines was induced for 24h by addition of 200ng/ml doxy-
cycline. Cells were ﬁxed for 7min in 3% (w/v)
paraformaldehyde including 0.1% (w/v) glutardialdehyde,
mounted in Vectashield containing DAPI and imaging
was performed on a Leica TCS SP5.
Protein puriﬁcation and gel ﬁltration analysis
Wild-type yeast ScNep1 and the D90G mutant with an
N-terminal 6xHis-tag were expressed from pQE-9
plasmids in Escherichia coli XL1-blue (Stratagene) and
puriﬁed using HIS-Select Nickel Afﬁnity Gel (Sigma).
Analytical gel ﬁltrations were performed at room tem-
perature on an A ¨ KTA FPLC system with a Superdex 75
100/300 column (GE Healthcare) equilibrated with
250mM NaCl, 25mM Tris/HCl, pH 7.5, 2mM
b-mercaptoethanol. Protein samples of 300ml with differ-
ent ScNep1 protein concentrations (1–216mM) were
prepared in the same buffer and equilibrated at 4 C for
at least 12h. The samples were loaded to the column using
a 100-ml loop and separated at a ﬂow rate of 0.5ml/min.
Absorbance was recorded at 280nm. Molecular mass
1528 Nucleic Acids Research, 2011,Vol.39, No. 4standards were conalbumin (75kDa), ovalbumin
(43kDa), carbonic anhydrase (29kDa) and ribonuclease
A (13.7kDa) (GE Healthcare). The molecular masses of
the standards were plotted versus log(M) to calculate the
apparent Nep1 molecular weights. Thereafter, the
apparent Nep1 molecular weights were plotted versus
the respective Nep1 protein concentration. To determine
the monomer/dimer dissociation constants, the following
equation which describes a monomer/dimer equilibrium
was ﬁtted to this curve using the nonlinear least square
algorithm of Origin 8 (OriginLab):
MWap ¼ MWM 2  
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
K2
Dap=16+cKDap=2
q
  KDap=4
  
=c
  
where MWap is the apparent molecular weight monomer,
MWM the molecular weight monomer, KDap the apparent
monomer/dimer dissociation constant and c Nep1 the
concentration applied to the column.
Fluorescence anisotropy measurements
For the ﬂuorescence anisotropy measurements a
50-ﬂuorescein labelled RNA (50-Fl-GACUCAACACG-30)
(Dharmacon) was used. Measurements were performed on
a Fluorolog 3 spectrometer (Horiba Jobin Yvon) at 20 C
in 2ml polystyrene cuvettes. Excitation and emission
wavelengths were set to 490nm and 516nm, respectively.
ScNep1 protein was dialysed against 100mM KCl, 25mM
Tris/HCl, 2mM b-mercaptoethanol, pH 7.5 before the ex-
periments and the same buffer was used during the anisot-
ropy measurements. For ScNep1
D90G measurements,
protein was added from concentrated stock solutions of
at least 45mM to a 20nM solution of RNA while for
ScNep1 wild-type measurements a 30mM protein
solution was adjusted to 20nM RNA concentration and
serially diluted with a 20nM RNA solution. Plotted data
points are means of at least three independent measure-
ments. The binding curves were ﬁtted to the equation
A ¼
c
c+KD
AI+AF
where A is the ﬂuorescence anisotropy, c Nep1 the
monomer concentration, KD the dissociation constant,
AI the increase of the ﬂuorescence anisotropy due to for-
mation of the RNA/Nep1 complex and AF the ﬂuores-
cence anisotropy of the free RNA, using the nonlinear
least square algorithm of Origin 8 (OriginLab) to obtain
the dissociation constants.
RNA methyltransferase activity assay
The RNA methylation activity was tested in a reaction
mixture containing 50mM KCl, 25mM Tris/HCl,
pH7.5, 500mM S-adenosylmethionine, 250mM RNA
(50-GACCAACACG-30) (Dharmacon) and 22mM
ScNep1. This mixture was incubated at 37 C for 30min.
For MALDI mass spectrometry samples from the RNA
methylation reaction were diluted 1:10 with pure water.
For mass analysis, 0.5ml sample solution were mixed
together with 2ml matrix solution directly on the
MALDI target and dried in a stream of air.
3-hydroxypicolinic acid (40mg/ml in water) containing
5mg/ml diammoniumhydrogencitrate was used as
matrix. Mass spectra were recorded on a MALDI
Orbitrap XL (Thermo Scientiﬁc) in positive ion mode.
Resolution at this instrument was set to 30000. Five to
ten spectra were accumulated over a maximum of 80 laser
shots, depending on the number of ions produced.
RESULTS
Identiﬁcation of the Nep1 methyltransferase target site
The ribosome biogenesis cofactor Nep1 has been shown
to possess a structure resembling that of members of
the SPOUT methyltransferase family (29,30). The
S. cerevisiae Nep1 RNA-binding motif which we identiﬁed
(37) occurs at three positions within the 18S rRNA (nu-
cleotides 349–354 near helix 12, 1190–1195 near helix 35
and 1566–1571 near helix 47 of yeast 18S rRNA). No base
modiﬁcations are known adjacent to or within helix 12.
Within the possible binding site of ScNep1 near helix 47,
G1575 is methylated at N7. Recently, it was suggested that
ScBud23 catalyses the G1575 N7-methylation (10). To
exclude a potential role of ScNep1 in the m7G modiﬁca-
tion we performed aniline cleavage experiments (38; see
also Supplementary Methods) with 18S rRNA from wild
type and a ScDnep1 Dtma23 yeast strain, where the
ScDtma23 deletion suppresses the lethal ScDnep1 pheno-
type (39). The 18S rRNA isolated from 40S subunits was
cleaved by aniline at the 7-methylguanine residue at
position 1575 resulting in a 30-terminal 215-nt-long
fragment in wild type. In the ScDnep1 Dtma23 strain the
G1575 base methylation was unaffected because the cor-
responding aniline induced cleavage still occurred,
indicating that ScNep1 is not responsible for this rRNA
modiﬁcation (Supplementary Figure S1).
As our in vitro experiments showed a speciﬁc pseudo-
uridine N1-methyltransferase activity of MjNep1 if this 
is located at a position corresponding to 1191 in the
putative Nep1 binding site (34), we focused our attention
to the region near helix 35 which contains the
hypermodiﬁed nucleotide m1acp3 at position 1191
(Figure 1A).
U1191 pseudouridylation requires the presence of the
snoRNA snR35 and recently Liang et al. (12) reported a
reduced translational rate, impaired ribosome function
and a delay in 20S rRNA processing in Dsnr35 deletants.
Therefore, we tested for possible genetic interactions of a
Scnep1-1
ts mutation with a ScDsnr35 deletion which
prevents pseudouridylation. Indeed, a minor synthetic
sick effect was observed for Scnep1-1
ts Dsnr35 recombin-
ants (Supplementary Figure S2) which provided evidence
that pseudouridylation may support Nep1 function. In
contrast to the recent report on a reduction in growth
upon ScDsnr35 deletion in S. cerevisiae (12) no effects
on growth became obvious, which shows that the
fast-growing CEN.PK strains due to a different genetic
background (40) do respond less sensitive to Dsnr35
deletion as compared to the strains used in (12).
Phenotypic differences upon gene deletions are often
found between different yeast strains (40).
Nucleic Acids Research,2011, Vol.39, No. 4 1529Helix 35 of 18S rRNA is strongly conserved in yeast and
humans (Figure 1A) and is also present in the 16S rRNA of
M. jannaschii. To investigate a possible function of Nep1 in
1191 modiﬁcation, we analysed the acp-modiﬁcation in
yeast 18S rRNA from wild-type cells and in a ScDnep1
Dnop6 strain, where the ScDnop6 deletion suppresses the
lethal ScDnep1 phenotype (39). We speciﬁcally labelled the
acp-group by cultivating wild-type and ScDnep1 Dnop6
cells with L-[1-
14C]-methionine because the C1- and
C2-atoms of methionine are incorporated via S-
adenosylmethionine into m1acp3 1191 (16). To enhance
14C-labelling efﬁciency we used methionine auxotrophic
yeast strains carrying a ScDmet13 deletion. Total RNA
was isolated, separated by acrylamide gel electrophoresis
and analysed for
14C-labelling of the 18S rRNA by auto-
radiography. Strains with point mutations of U1191 to
adenosine or cytosine served as controls for the speciﬁcity
of the radioactive signal. Replacement of U1191 by any
other base caused signiﬁcant growth deﬁciencies. While
strains with the wild-type rDNA plasmid had generation
timesof2h30min,U1191Greplacementincreasedthegen-
eration times to 3h 10min, U1191A replacement to 3h
40min and U1191C replacement even to 5h. The severe
impact of U1191 replacement by any other base not only
clearly shows the importance of U1191 for ribosome bio-
genesis and/or function, but also shows that a failure in
1191 modiﬁcation does not explain the essential pheno-
type of a ScDnep1 deletion.
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Figure 1. Analysis of the U1191 yeast 18S rRNA hypermodiﬁcation. (A) The predicted secondary structure of a region of 18S rRNA
(www.rna.ccbb.utexas.edu/) containing helix 35 and the hypermodiﬁed nucleotide m1acp3 (1191 in S. cerevisiae, 1248 in H. sapiens) is shown.
(B) Speciﬁc
14C-aminocarboxypropyl-labeling of yeast 18S rRNA nucleotide U1191 with L-[1-
14C]-methionine. The asterisk indicates the
14C-label
(top). Total RNA was isolated from ScDmet13 cells after growth with L-[1-
14C]-methionine and separated by acrylamide gel electrophoresis (bottom).
(Upper part) Ethidium bromide staining of RNA gels. (Lower part) Autoradiography of RNA gels. Samples of 5 and 10ml total RNA from wild
type (CEN.NM1-4D: WT, lanes 1, 2 and 9), rDNA deleted strains with plasmid encoded wild-type rDNA (CEN.BM146-1C: 1191, lanes 3 and 4),
plasmid encoded rDNA mutations U1191C (CEN.BM147-1C: 1191C, lanes 5 and 6), U1191A (CEN.BM148-1C: 1191A, lanes 7 and 8), a
ScDsnr35 deleted strain (CEN.BM141-7G: Dsnr35, lanes 10 and 11) and a ScDnep1 Dnop6 deleted strain (CEN.BM140-11B: Dnep1 Dnop6, lanes
12 and 13) were loaded on the gel.
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RNA and a subsequent autoradiography no radiolabelling
was observed for the A1191 and C1191 rRNA mutants
(Figure 1B), whereas a weak but clear radioactive signal
of 18S rRNA from the wild type was present. This clearly
showed that the acp group of
14C-methionine was specif-
ically incorporated into 18S rRNA and also conﬁrmed
that 1191 is the only base with an acp modiﬁcation in
the 18S rRNA. In case of the ScDnep1 Dnop6 double
mutant, 18S rRNA was
14C-labelled like wild type,
demonstrating that Nep1 had no inﬂuence on the
acp-modiﬁcation of 1191. Interestingly, the 18S rRNA
of a ScDsnr35 mutant which prevents pseudouridylation
at this position also contained the acp-modiﬁcation,
showing that the N3-position of U1191 can also be
acp-modiﬁed (Figure 1B), which is in accordance with a
strong stop in recent 18S rRNA primer extension studies
with ScDsnr35 mutants (12).
The SPOUT methyltransferase Nep1 is required for
)1191 methylation
We then used the
14C-acp label to identify the modiﬁed
1191 nucleosides in yeast wild-type and ScDnep1
deletion strains. The 18S rRNAs from wild-type and
ScDnep1Dnop6 mutants were hydrolysed and
dephosphorylated, and the resulting nucleosides were
separated by RP-HPLC. The
14C-labelled nucleosides
from wild type eluted 9.4min after the elution gradient
was started, whereas
14C-labelled nucleosides from
ScDnep1Dnop6 mutants had already eluted at 5.7min
(Figure 2A). An acp-labelled U1191 isolated from a
ScDsnr35 snoRNA mutant that lacks pseudouridylation
was eluted after 10.9min (Figure 2A).
The altered elution time of the
14C-acp-labelled nucleo-
side in the ScDnep1Dnop6 mutant suggested a change in
the  N1-modiﬁcation pattern. To elucidate the chemical
nature of the acp-modiﬁed nucleosides the 18S rRNAs
from wild-type and mutant strains were puriﬁed in large
scale, hydrolyzed and separated by RP-HPLC. The ratio
of modiﬁed 1191 nucleosides to the other major nucleo-
sides (A, U, G, C) is  1:400, which makes their isolation
difﬁcult. However, small peaks corresponding to the dif-
ferently modiﬁed 1191 in the RP-HPLC proﬁle could be
identiﬁed using the
14C-label (Figure 2B).
In addition, the 1191-modiﬁed nucleosides were
analysed by electro spray ionization (ESI) mass spectrom-
etry analysis. The molecular mass of the 1191-modiﬁed
nucleosides from wild type of 358.1215Da [M-H] corres-
ponded to the expected theoretical mass of m1acp3
(C14H21N3O8 [M-H]: 358.1256Da) (Supplementary
Figure S3A). For the ScDnep1Dnop6 mutant the molecular
mass of 344.1099Da [M-H] was exactly as the theoretical
mass of the non-methylated acp3 nucleoside
(Supplementary Figure S3B). Thus, the absence of Nep1
in a ScDnep1Dnop6 mutant results in the elimination of the
methylation at position 1191, demonstrating that Nep1 is
the methyltransferase responsible for the in vivo methyla-
tion of 1191 in the 18S rRNA in yeast.
Functional analysis of the BCS yeast Nep1
D90G mutation
Our recent molecular analysis of the human BCS showed
that this rare and severe disease is caused by a point
mutation resulting in a D86G exchange in human Nep1
(27). To analyse the Nep1 malfunction in BCS, the BCS
mutation was introduced into yeast Nep1 (ScNep1
D90G)
and the resulting reading frame was placed under the
recently described tetracycline aptamer regulatory
system, where addition of tetracycline prevents translation
of the corresponding mRNA (41). This allowed a gradual
down-regulation of ScNep1 expression with increasing
tetracycline concentrations. Without tetracycline no
growth difference was observed for the ScNep1 wild
type and the ScNep1
D90G BCS mutation. However,
when the expression of ScNep1 and ScNep1
D90G was
down-regulated, growth of the BCS mutant was signiﬁ-
cantly slowed down as compared to the wild type
(Figure 3A). The expression levels of ScNep1 and
ScNep1
D90G with and without tetracycline were very
similar (Figure 3B). This clearly shows that the BCS
mutation inﬂuences growth in yeast, consistent with the
human condition.
The BCS protein loses its nucleolar localization
For further analysis, the cellular localization of the yeast
(ScNep1
D90G) and human (HsNep1
D86G) BCS proteins
was analysed using GFP-fusions. In yeast, the GFP-
ScNep1
D90G fusion complemented growth in a ScDnep1
deletion after its multi-copy expression. Interestingly, the
BCS ScNep1
D90G protein lost its exclusive nuclear local-
ization. In GFP-ScNep1 wild-type cells a strong
super-imposed signal was seen with Nop56-mRFP,
which was used as a nucleolar marker, whereas for the
GFP-ScNep1
D90G fusion the nuclear localization was
strongly reduced and it showed distinct cytoplasmic
staining (Figure 4A).
An even more pronounced effect was found for the
human BCS HsNep1
D86G protein in stable human 293T
cell lines that express GFP-fusions of human Nep1 wild
type or the Nep1
D86G mutant. While wild-type
HsNep1-GFP localized to the nucleus and showed
strong nucleolar staining, the HsNep1
D86G-GFP mutant
was nucleoplasmic but did not accumulate in the nucleolus
and instead showed a weak cytoplasmic signal
(Figure 4B). This is in accordance with our previous
ﬁndings that the human D86G mutant protein showed a
reduced nuclear level in BCS patient ﬁbroblasts (27).
Importantly, the BCS mutant loses its nucleolar localiza-
tion, which could explain the malfunction in ribosome
biogenesis and the BCS.
The BCS proteins show increased dimerization in vitro
Analysis of the human HsNep1
D86G protein showed a
strongly increased interaction of the monomers in the
yeast two-hybrid system (27). To biochemically conﬁrm
an enhanced BCS protein interaction yeast wild-type and
yeast ScNep1
D90G proteins were expressed with an
N-terminal hexahistidine tag (H6)i nE. coli, afﬁnity
puriﬁed and separated by gel ﬁltration. Analytical gel
Nucleic Acids Research,2011, Vol.39, No. 4 1531ﬁltrations over a wide range of different protein concen-
trations showed a concentration-dependent monomer/
dimer equilibrium for the wild-type H6-ScNep1 protein
(Figure S4A). At low protein concentration (1mM)
wild-type H6-ScNep1 was eluted at  32kDa, which is
close to the molecular mass of the monomer (calculated
molecular mass, 28.9kDa), whereas at higher H6-ScNep1
protein concentrations the equilibrium was shifted
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Figure 2. U1191 modiﬁcations in wild type, ScDsnr35 and ScDnep1 Dnop6 mutants. (A) RP-HPLC analysis of 18S rRNA nucleosides from ScDmet13
deleted acp-
14C-labelled cells. 18S rRNAs were isolated from denaturing polyacrylamide gels, hydrolysed and dephosphorylated to nucleosides, which
were separated on an HXSil-C18 column. Fractions of 15s each were collected and
14C scintillation was counted. Dotted lines correspond to the
scintillation proﬁle, solid lanes correspond to the HPLC-spectrum detected at 254nm. Peaks of standard nucleosides (C, U, G, A) are indicated.
(B) Elution proﬁles of nucleosides from wild type (upper part) and a ScDnep1 Dnop6 mutant (lower part). 18S rRNAs were isolated from 40S
ribosomal subunits, hydrolysed and dephosphorylated prior to RP-HPLC separation with a Supelcosil LC-18-S column.
1532 Nucleic Acids Research, 2011,Vol.39, No. 4towards the dimeric form (48kDa at protein concentra-
tion of 216mM, calculated molecular mass: 57.8kDa). By
contrast, comparable gel ﬁltrations with the H6-Nep1
D90G
protein (Figure S4B) always provided higher molecular
weights as compared to the H6-ScNep1 wild-type
protein. The strong difference between the H6-ScNep1
and the H6-ScNep1
D90G mutant protein became even
more obvious when the molecular weights were plotted
against the protein concentrations (Figure 5A). These
data clearly show that the ScNep1
D90G mutation caused
strongly enhanced dimerization as compared to the
wild-type ScNep1 protein. Based on the equation for
monomer/dimer equilibria the data were ﬁtted to the
curve to calculate apparent monomer/dimer dissociation
constants (see ‘Materials and Methods’ section). The
ScNep1
D90G mutant apparent KD (5.8±3.2mM) was
more than 23-fold lower as compared to the ScNep1
wild-type apparent KD (134.5±17mM), which explains
the strongly enhanced dimerization of the ScNep1
D90G
mutant protein. The apparent molecular weights for the
wild-type monomer (MWap=31.1kDa) and the mutant
monomer (MWap=30.7kDa) derived from this ﬁttings
were remarkably close to the expected molecular weight
of the monomer (MW=28.9kDa) and conﬁrm the
accuracy of the measurements.
The BCS proteins have increased RNA afﬁnity in vitro
As only the Nep1 dimer can efﬁciently bind to the target
RNA, we assumed that the ScNep1
D90G mutant protein
might have an increased RNA-binding afﬁnity. Therefore,
we determined the RNA/Nep1 dissociation constants by
ﬂuorescence anisotropy measurements using 50-ﬂuorescein
labelled RNA (50-Fl-GACUCAACACG-30) (Figure 5B).
Indeed the dissociation constant of ScNep1
D90G
(KD=0.36±0.04mM) was 17-fold decreased as
compared to that of wild-type ScNep1 (KD=
6.29±0.98mM). This shows a strongly increased
RNA-binding afﬁnity of the BCS-mutated Nep1 protein.
)1191 methylation activity of the yeast BCS
D90G
mutated Nep1
Our ﬁnding that the BCS yeast ScNep1 mutation increases
dimerization motivated us to analyse the methylation
activity of the BCS-mutated enzyme. According to our
recently developed Nep1 in vitro methylation assay (34),
we used an RNA oligonucleotide equivalent to nucleotides
1188–1198 of yeast 18S rRNA as substrate (50-GACCA
Figure 4. Intracellular localization of BCS-mutated Nep1 proteins.
(A) Cellular localization of yeast wild-type ScNep1 (upper part) and
the D90G mutant (lower part) using confocal microscopy. Both
proteins were expressed as GFP-fusion together with the
ScNop56-mRFP protein as a nucleolar marker. (Left) Green ﬂuores-
cence (ScNep1); (middle) red ﬂuorescence (ScNop56); (right) merge
with differential interference contrast (DIC). (B) Intracellular localiza-
tion of human HsNep1 (upper part) and the HsNep1
D86G mutant
(lower part) after 24h induction with 200ng/ml doxycycline. The
cellular localizations of the GFP-fusion proteins were analysed by
confocal microscopy. (Left) Green ﬂuorescence; (middle) DAPI
staining; (right) merge with differential interference contrast (DIC).
Scale bar: 10mm.
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Figure 3. Functional analysis of the yeast Bowen–Conradi syndrome
mutation. (A) ScNep1
D90G mutant growth defect after partial transla-
tional repression. Wild-type ScNEP1 (CEN.PK935-2B) or Scnep1
D90G
(CEN.BM113-4A) were expressed under control of the ScTDH3-
promotor and three tc-aptamers. Serial dilutions were spotted on
YEPD plates without or with 20mM tetracycline. (B) Quantiﬁcation
of 3xHA-Nep1 and 3xHA-Nep1
D90G expression by western blot
analysis. The 3xHA-Nep1 and 3xHA-Nep1
D90G levels were detected
after 8h growth without (–) or after addition of 20 or 50mM tetracyc-
line (+) to yeast strains CEN.PK935-2B (TDH3p-tc-3xHA-NEP1) and
CEN.BM113-4A (TDH3p-tc-3xHA-nep1
D90G).
Nucleic Acids Research,2011, Vol.39, No. 4 1533ACACG-30) and analyzed the reaction products by
MALDI-mass spectrometry. Thereby we could show
that the yeast BCS protein methylated the target RNA
as efﬁciently as the ScNep1 wild-type protein in vitro
(Figure 6). These data suggest that Nep1, in addition to
rRNA methylation, has a second role in ribosome
biogenesis.
S-adenosylmethionine suppression of nep1-1
ts is
independent of )1191 methylation
A dual Nep1 function was also strongly supported by
results from recombination experiments of the ScDsnr35
mutation with the previously described Scnep1-1
ts
mutation which grows at elevated temperature if sup-
pressed by an external S-adenosylmethionine supply
(26). External S-adenosylmethionine suppressed the
ScDsnr35 nep1-1
ts strain, although this strain cannot
methylate U1191 due to the ScDsnr35 deletion
(Figure 7). Thus, substrate (S-adenosylmethionine)
binding restores ScNep1-1
ts function even if it is not
required as a substrate for RNA methylation.
DISCUSSION
Ribosome biogenesis is one of the most complex biosyn-
thetic pathways in eukaryotic cells. It is highly regulated
and in addition to the 79 core proteins of the ribosome,
 180 proteins and 75 snoRNAs are required for ribosome
synthesis (4–6). The additional proteins and snoRNAs
fulﬁl two major functions, either rRNA processing and
modiﬁcation or ribosome assembly. Although the
speciﬁc molecular function of most rRNA modiﬁcations
is still not resolved, many of these modiﬁcations are highly
conserved in eukaryotic rRNAs, which clearly shows their
physiological importance. A unique modiﬁcation is the
uracil hypermodiﬁcation in yeast (U1191) and human
(U1248) 18S rRNA (11), which is similar to modiﬁcations
found in some archaea (17). U1191 is located in loop 35 of
the yeast 18S rRNA in the decoding region of the
ribosome and has been shown to be important for
ribosome function (12). The rRNA sequence of loop 35
in yeast is strongly conserved in the human 18S rRNA
Figure 5. Dimerization and RNA-binding afﬁnity of BCS-mutated yeast ScNep1
D90G.( A) Apparent molecular weights of ScNep1 (squares) and
ScNep1
D90G (circles) calculated from retention volumes after gel ﬁltrations at nine different protein concentrations (1–216mM) are plotted versus the
ScNep1 concentration to calculate the apparent monomer/dimer dissociation constants. Dissociation constants derived from the ﬁts were 134.5
(±17)mM for wild-type ScNep1 and 5.8 (±3.2)mM for ScNep1
D90G. The calculated apparent molecular weights of the monomers were 31.1
(±0.4)kDa for wild-type ScNep1 and 30.7 (±1.4)kDa for ScNep1
D90G.( B) ScNep1 binding to a 50-ﬂuorescein labelled RNA
(50-Fl-GACUCAACACG-30) determined by ﬂuorescence anisotropy. Shown are mean and standard deviation of three measurements. The
binding curves were ﬁtted to a one site binding model with one binding site per monomer. Dissociation constants derived from the ﬁt are 6.29
(±0.98)mM for wild-type ScNep1 and 0.38 (±0.04)mM for ScNep1
D90G.
Figure 6. RNA-methylation activity of wild type and BCS-mutated
ScNep1. Analysis of in vitro RNA-methylation with yeast ScNep1
and BCS-mutated ScNep1
D90G. MALDI mass spectra of an RNA
oligonucleotide (50-GACCAACACG-30) containing a pseudouridine
in the position corresponding to nucleotide 1191. The mass of the
RNA oligonucleotide (upper part) increases by 14Da 30min after
addition of S-adenosylmethionine (ScNep1, middle part, ScNep1
D90G-
mutated protein, lower part).
1534 Nucleic Acids Research, 2011,Vol.39, No. 4(see also Figure 1A) which also supports its signiﬁcance
for ribosome function. The hypermodiﬁcation of U1191
involves three modiﬁcation steps: First, a
pseudouridylation supported by snoRNA snR35 in yeast
or snoRNA ACA13 in humans; second, N1-methylation;
and, third, N3-acp modiﬁcation, resulting in 1-methyl-3-
(3-amino-3-carboxypropyl)-pseudouracil. Whereas the
acp-modiﬁcation takes place in the cytoplasm, the
N1-methylation occurs during ribosome biogenesis in
the nucleus.
Here, we show that the SPOUT methyltransferase Nep1
(Emg1) catalyses the N1-1191 methylation in vivo.
Interestingly, our results with ScDsnr35 deletion mutants
show that the methylation is speciﬁc for , whereas the
cytoplasmic acp-modiﬁcation also occurs at the N3
position of uracil which is in accordance with recent
ﬁndings (12). Furthermore, a reduced translation rate
and impaired ribosome function were also reported for
ScDsnr35 deletion mutants (12). The fact that the remain-
ing U1191 is still acp-modiﬁed possibly indicates that
missing N1-methylation might cause these effects.
The functional importance of U1191 in the 18S rRNA is
further supported by our ﬁnding that replacement of
U1191 by any other base had a strong impact on yeast
growth. While replacement with G and A caused signiﬁ-
cant growth retardation, C1191 replacement mutants were
hardly viable. This could be due to either structural effects
or the fact that these mutations interfere with Nep1
binding. Nevertheless, the G/C/A1191 mutations were
viable, which shows that the absence of an
N1-methylation at 1191 does not explain the lethal
phenotype of a ScDnep1 mutation. This clearly shows
that Nep1 1191 methylation is not the only function of
Nep1. This also became obvious in the ScNep1-1
ts experi-
ments with S-adenosylmethionine. Even after ScDsnr35
deletion when no U1191 pseudouridylation and, as
shown here and previously (12), no N1-methylation
occurs, the addition of S-adenosylmethionine restores
growth of a Scnep1-1
ts mutant at elevated temperatures.
Our results clearly show a dual function of Nep1 as a
methyltransferase and as an assembly protein in
ribosome biogenesis. This is also in accordance with the
recent observation that ScNep1 mutations which prevent
S-adenosylmethionine binding can still provide the
essential Nep1 function (29). Similar ﬁndings have also
been reported for ScDim1 which catalyses the
N-dimethylation of A1781 and A1782 at the 30 end of
the 18S rRNA (9) and also for ScBud23, recently shown
to catalyse the N7-methylation of G1575 (10).
Interestingly, all three RNA modiﬁcations are dispensable
for cell viability although ScNep1, ScDim1 and ScBud23
are essential for growth and ribosome biogenesis.
The dual function of Nep1 is also of major importance
for the human BCS, where a speciﬁc missense mutation
causes a severe disorganization of ribosome biogenesis
(27). Therefore, unravelling the physiological function of
the Nep1 protein in ribosome biogenesis is of key import-
ance to understand the molecular basis for this severe
developmental disease and to possibly develop strategies
to compensate for its malfunction. Fortunately, Nep1 is a
highly conserved eukaryotic protein and the human Nep1
protein is functional in yeast (26), which allows the use of
yeast as a model system to study Nep1 function in
ribosome biogenesis.
Although the corresponding yeast BCS protein
(ScNep1
D90G protein) still methylated its target RNA
almost as efﬁciently as the ScNep1 wild-type protein, the
D90G mutant was less viable. In yeast and human Nep1
the BCS mutation causes several severe changes in the
physical properties of the protein. Importantly, these are
increased dimerization and decreased protein stability
(data not shown) which in consequence results in
strongly diminished levels of Nep1 in the nucleolus. This
is in accordance with several experimental data: the
reduced amount of Nep1
D86G in the nuclei of patient
ﬁbroblasts as compared to healthy ﬁbroblasts (27), the
strongly diminished amount of ScNep1
D90G in the yeast
nucleus, and the fact that stable human cell lines do not
accumulate HsNep1
D86G in the nucleolus. Possibly,
increased dimerization might reduce BCS-mutated Nep1
import into the nucleus in yeast (and less severely also in
human cells), abolish its nucleolar accumulation in human
cells (and less severely in yeast) and/or disturb Nep1 inter-
action with co-factors, thereby preventing its function as a
ribosome assembly protein. These ﬁndings further support
a dual function of Nep1 in ribosome biogenesis. While the
BCS mutation does not interfere with RNA methylation
in vitro, the observed malfunction may directly interfere
with ribosome biogenesis. Afﬁnity capture studies showed
that ScNep1 forms a macromolecular complex with
several ribosome assembly proteins (e.g. ScNop14,
ScNop1, ScNoc4, ScUtp30 and ScKrr1) (42,43).
Additionally, we have previously observed that multi-copy
expression of ScRps19, a protein of the small ribosome
subunit, suppresses the Scnep1-1
ts phenotype more efﬁ-
ciently as compared to the ScDnep1 deletion, indicating
that Nep1 supports Rps19 entry into the pre-ribosomal
complex (37).
In summary, we show for the ﬁrst time that yeast Nep1
catalyses the in vivo N1-methylation of the unique
hypermodiﬁed 1191 within the decoding region of the
ribosome and that the mutation causing the BCS has
no effect on the catalytic function of Nep1. Instead, it
leads to severe changes in the physical properties of
Nep1, which most likely prevent its accumulation in the
nucleolus and its subsequent function as a ribosome
assembly protein.
Δsnr35
nep1-1ts
Δsnr35 nep1-1ts
YEPD 30°C YEPD + SAM 30°C
Figure 7. S-adenosylmethionine suppression of the Scnep1-1
ts mutant
incubated at 30 C. Yeast strains CEN.PK1016-9C (ScDsnr35),
CEN.PK1016-4C (Scnep1-1
ts) and CEN.PK1016-7A (Scnep1-1
ts
Dsnr35) were spotted on YEPD medium without (left) or with
S-adenosylmethionine (0.2mg/ml, right).
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